<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02616757</url>
  </required_header>
  <id_info>
    <org_study_id>1000049774</org_study_id>
    <nct_id>NCT02616757</nct_id>
  </id_info>
  <brief_title>Quantitative Ultrasound for the Evaluation of Simple Bone Cyst Healing</brief_title>
  <official_title>Quantitative Ultrasound for the Evaluation of Simple Bone Cyst Healing</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>The Hospital for Sick Children</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>The Hospital for Sick Children</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Simple bone cysts (SBCs), also known as unicameral bone cysts (UBCs), are benign bone&#xD;
      lesions. Literature to date describes little agreement between clinicians on specific&#xD;
      prognostic criteria for the prediction of cyst healing, recurrence or fracture. Evidence has&#xD;
      shown that bone mineral density (BMD) is a reliable indicator of risk to SBC patients given&#xD;
      its association with the mechanical properties of bone. There has been further exploration&#xD;
      into the use of quantitative ultrasound to assess bone density by measuring the velocity of&#xD;
      the ultrasound transmission over the bone. To determine whether the QUS can provide&#xD;
      prognostic information with respect to cyst healing, recurrence or fracture with a SBC,&#xD;
      further study is needed.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Withdrawn</overall_status>
  <why_stopped>
    Ultrasound machine was no longer approved for use by Health Canada therefore study was closed&#xD;
    prior to patients being enrolled on study.&#xD;
  </why_stopped>
  <start_date>October 2016</start_date>
  <completion_date type="Actual">January 6, 2021</completion_date>
  <primary_completion_date type="Actual">January 6, 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Z-scores obtained using quantitative ultrasound</measure>
    <time_frame>2 years</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Bone specific alkaline phosphatase</measure>
    <time_frame>2 years</time_frame>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Actual">0</enrollment>
  <condition>Simple Bone Cyst</condition>
  <arm_group>
    <arm_group_label>Simple Bone Cyst Patients</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Z-score measurements will be taken from the mid-shaft tibia and distal third of the radius of both extremities where possible using quantitative ultrasound at baseline and once annually for 2 years.&#xD;
There will also be optional blood samples taken o measure bone alkaline phosphatase.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Fracture patients</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Z-score measurements will be taken from the mid-shaft tibia and distal third of the radius of both extremities where possible using quantitative ultrasound at baseline, after 3 months and at future follow-up visits as clinically indicated or at a one year follow-up visit.&#xD;
There will also be optional blood samples taken to measure bone alkaline phosphatase.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Health volunteers</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Z-score measurements will be taken from the mid-shaft tibia and distal third of the radius of both extremities where possible using quantitative ultrasound at baseline, after 3 months and at a one year follow-up visit.&#xD;
There will also be optional blood samples taken to measure bone alkaline phosphatase.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Sunlight Omnisense Quantitative Ultrasound</intervention_name>
    <description>Ultrasound</description>
    <arm_group_label>Fracture patients</arm_group_label>
    <arm_group_label>Health volunteers</arm_group_label>
    <arm_group_label>Simple Bone Cyst Patients</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Arm 1 - Simple Bone Cyst Patients&#xD;
&#xD;
        Inclusion Criteria&#xD;
&#xD;
          1. Patients ≥ 2 and ≤ 21 years&#xD;
&#xD;
          2. Patients with a diagnosis of simple bone cyst located in a long bone confirmed by&#xD;
             imaging within 3 months prior to registration&#xD;
&#xD;
          3. All patients and/or their parents or legally authorized representatives must sign a&#xD;
             written informed consent. Assent, when appropriate, will be obtained according to&#xD;
             institutional guidelines.&#xD;
&#xD;
        Exclusion Criteria&#xD;
&#xD;
          1. Patients with implants to stabilize the bone where the cyst is located.&#xD;
&#xD;
          2. Patients with bone disease (i.e. osteogenesis imperfecta, cancer, osteoporosis,&#xD;
             Paget's disease)&#xD;
&#xD;
          3. Patients who are pregnant or breastfeeding&#xD;
&#xD;
          4. Patients with a simple bone cyst crossing the growth plate&#xD;
&#xD;
        Arm 2 - Healthy Controls&#xD;
&#xD;
        Inclusion Criteria&#xD;
&#xD;
          1. Patients ≥ 2 and ≤ 21 years&#xD;
&#xD;
          2. All patients and/or their parents or legally authorized representatives must sign a&#xD;
             written informed consent. Assent, when appropriate, will be obtained according to&#xD;
             institutional guidelines.&#xD;
&#xD;
        Exclusion Criteria&#xD;
&#xD;
          1. Patients with bone disease (i.e. osteogenesis imperfecta, cancer, osteoporosis,&#xD;
             Paget's disease)&#xD;
&#xD;
          2. Patients receiving any bone-modifying agents (i.e. steroids, bisphosphanates, etc.)&#xD;
&#xD;
          3. Patients who are pregnant or breastfeeding&#xD;
&#xD;
        Arm 3 - Fracture patients&#xD;
&#xD;
        Inclusion Criteria&#xD;
&#xD;
          1. Patients ≥ 2 and ≤ 21 years&#xD;
&#xD;
          2. Patients who have undergone any type of casting or surgical treatment for their&#xD;
             fracture&#xD;
&#xD;
          3. All patients and/or their parents or legally authorized representatives must sign a&#xD;
             written informed consent. Assent, when appropriate, will be obtained according to&#xD;
             institutional guidelines.&#xD;
&#xD;
        Exclusion Criteria&#xD;
&#xD;
          1. Patients with bone disease (i.e. osteogenesis imperfecta, cancer, osteoporosis,&#xD;
             Paget's disease)&#xD;
&#xD;
          2. Patients receiving any bone-modifying agents (i.e. steroids, bisphosphanates, etc.)&#xD;
&#xD;
          3. Patients who are pregnant or breastfeeding&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>2 Years</minimum_age>
    <maximum_age>21 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Andrew Howard, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>The Hospital for Sick Children</affiliation>
  </overall_official>
  <overall_official>
    <last_name>James G. Wright, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Nuffield Orthopaedic Centre</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>The Hospital for Sick Children</name>
      <address>
        <city>Toronto</city>
        <state>Ontario</state>
        <zip>M5G 1X8</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Canada</country>
  </location_countries>
  <verification_date>April 2021</verification_date>
  <study_first_submitted>November 25, 2015</study_first_submitted>
  <study_first_submitted_qc>November 25, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">November 30, 2015</study_first_posted>
  <last_update_submitted>April 20, 2021</last_update_submitted>
  <last_update_submitted_qc>April 20, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">April 21, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>The Hospital for Sick Children</investigator_affiliation>
    <investigator_full_name>James Wright</investigator_full_name>
    <investigator_title>Orthopaedic Surgeon</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Cysts</mesh_term>
    <mesh_term>Bone Cysts</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

